Histiocytic Sarcoma in Dogs
Histiocytic Sarcoma is a high-severity cancer condition that can affect dogs of all ages and breeds. Histiocytic sarcoma is a highly aggressive malignant tumour arising from dendritic cells or macrophages. Disseminated histiocytic sarcoma (formerly malignant histiocytosis) involves multiple organs simultaneously. Prognosis is uniformly poor. It is documented across 4 breeds, though prevalence and severity can differ significantly between them. It typically becomes apparent at 6-10 years. Early signs to watch for include rapid weight loss, anaemia, lethargy, and enlarged lymph nodes and spleen. When treatment is required, costs are estimated at £2,000-£6,000 depending on severity, location, and the specific intervention needed. Histiocytic Sarcoma has a hereditary component, so health-screening certificates from the breeder are strongly recommended for predisposed breeds. This page covers symptoms, treatment options, and preventive steps — along with breed-specific information where available.
Signs & Symptoms
The following symptoms are commonly associated with Histiocytic Sarcoma in dogs. If your dog displays several of these signs, consult your vet promptly — early diagnosis typically leads to better outcomes.
- Rapid weight loss
- Anaemia
- Lethargy
- Enlarged lymph nodes and spleen
- Respiratory signs
- Neurological signs
Treatment Overview
Lomustine (CCNU) chemotherapy is the most effective palliation and can achieve temporary remission. Median survival even with treatment is 4-6 months. Local forms treated by surgery have better outcomes.
Typical onset: 6-10 years
Prevention & Screening
While not all cases of Histiocytic Sarcoma can be prevented, the following steps reduce risk or enable earlier intervention:
- No proven prevention
- Genetic predisposition research ongoing
Estimated Treatment Cost
Treatment for Histiocytic Sarcoma is estimated at £2,000-£6,000, depending on severity, the specific intervention required, and your location. Costs may be higher for surgical procedures or ongoing management. Comprehensive pet insurance covering hereditary conditions is strongly recommended.
Breeds Affected by Histiocytic Sarcoma
The following 4 breeds are documented as being susceptible to Histiocytic Sarcoma. Click any breed to view breed-specific information about this condition, including prevalence and recommended screening.
Looking for more information? Browse all dog health conditions or explore the health guides for in-depth breed care advice.